OM:GETI B

Stock Analysis Report

Executive Summary

Getinge AB provides products and solutions for operating rooms, intensive-care units, sterilization departments, and life science companies and institutions.


Snowflake Analysis

Excellent balance sheet and good value.


Similar Companies

Share Price & News

How has Getinge's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: GETI B's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

14.5%

GETI B

13.5%

SE Medical Equipment

11.7%

SE Market


1 Year Return

79.3%

GETI B

10.4%

SE Medical Equipment

-9.7%

SE Market

Return vs Industry: GETI B exceeded the Swedish Medical Equipment industry which returned 5.7% over the past year.

Return vs Market: GETI B exceeded the Swedish Market which returned -10.3% over the past year.


Shareholder returns

GETI BIndustryMarket
7 Day14.5%13.5%11.7%
30 Day22.8%-3.1%-16.3%
90 Day13.0%-13.3%-21.1%
1 Year80.7%79.3%12.2%10.4%-7.1%-9.7%
3 Year58.8%27.0%34.0%18.8%2.2%-12.9%
5 Year16.9%-9.1%29.6%7.0%10.1%-13.0%

Price Volatility Vs. Market

How volatile is Getinge's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Getinge undervalued compared to its fair value and its price relative to the market?

30.9%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: GETI B (SEK196.55) is trading below our estimate of fair value (SEK284.4)

Significantly Below Fair Value: GETI B is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: GETI B is good value based on its PE Ratio (43.8x) compared to the Medical Equipment industry average (47.4x).

PE vs Market: GETI B is poor value based on its PE Ratio (43.8x) compared to the Swedish market (14.1x).


Price to Earnings Growth Ratio

PEG Ratio: GETI B is poor value based on its PEG Ratio (2.6x)


Price to Book Ratio

PB vs Industry: GETI B is good value based on its PB Ratio (2.6x) compared to the SE Medical Equipment industry average (3.6x).


Next Steps

Future Growth

How is Getinge forecast to perform in the next 1 to 3 years based on estimates from 10 analysts?

16.9%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: GETI B's forecast earnings growth (16.9% per year) is above the savings rate (-0.4%).

Earnings vs Market: GETI B's earnings (16.9% per year) are forecast to grow faster than the Swedish market (7.8% per year).

High Growth Earnings: GETI B's earnings are forecast to grow, but not significantly.

Revenue vs Market: GETI B's revenue (4% per year) is forecast to grow slower than the Swedish market (4.1% per year).

High Growth Revenue: GETI B's revenue (4% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: GETI B's Return on Equity is forecast to be low in 3 years time (9.8%).


Next Steps

Past Performance

How has Getinge performed over the past 5 years?

-34.8%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: GETI B has high quality earnings.

Growing Profit Margin: GETI B became profitable in the past.


Past Earnings Growth Analysis

Earnings Trend: GETI B's earnings have declined by -34.8% per year over the past 5 years.

Accelerating Growth: GETI B has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: GETI B has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (12.6%).


Return on Equity

High ROE: GETI B's Return on Equity (6%) is considered low.


Next Steps

Financial Health

How is Getinge's financial position?


Financial Position Analysis

Short Term Liabilities: GETI B's short term assets (SEK14.5B) exceed its short term liabilities (SEK9.9B).

Long Term Liabilities: GETI B's short term assets (SEK14.5B) exceed its long term liabilities (SEK13.9B).


Debt to Equity History and Analysis

Debt Level: GETI B's debt to equity ratio (43.4%) is considered high.

Reducing Debt: GETI B's debt to equity ratio has reduced from 111% to 43.4% over the past 5 years.

Debt Coverage: GETI B's debt is well covered by operating cash flow (42.1%).

Interest Coverage: GETI B's interest payments on its debt are well covered by EBIT (6.6x coverage).


Balance Sheet

Inventory Level: GETI B has a low level of unsold assets or inventory.

Debt Coverage by Assets: GETI B's debt is covered by short term assets (assets are 1.6x debt).


Next Steps

Dividend

What is Getinge's current dividend yield, its reliability and sustainability?

0.76%

Current Dividend Yield


Upcoming Dividend Payment


Dividend Yield vs Market

Notable Dividend: GETI B's dividend (0.76%) isn’t notable compared to the bottom 25% of dividend payers in the Swedish market (2.14%).

High Dividend: GETI B's dividend (0.76%) is low compared to the top 25% of dividend payers in the Swedish market (6.55%).


Stability and Growth of Payments

Stable Dividend: GETI B is not paying a notable dividend for the Swedish market, therefore no need to check if payments are stable.

Growing Dividend: GETI B is not paying a notable dividend for the Swedish market, therefore no need to check if payments are increasing.


Current Payout to Shareholders

Dividend Coverage: GETI B is not paying a notable dividend for the Swedish market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of GETI B's dividend in 3 years as they are not forecast to pay a notable one for the Swedish market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

3.0yrs

Average management tenure


CEO

Mattias Perjos (47yo)

3s

Tenure

kr46,043,000

Compensation

Mr. Mattias Perjos has been the Chief Executive Officer and President at Getinge AB since March 27, 2017. Mr. Perjos serves as Chief Executive Officer at FlexLink Systems, Inc. Mr. Perjos has been the Dire ...


CEO Compensation Analysis

Compensation vs Market: Mattias's total compensation ($USD4.59M) is above average for companies of similar size in the Swedish market ($USD1.35M).

Compensation vs Earnings: Mattias's compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Mattias Perjos
CEO, President & Director3yrskr46.04m0.013% SEK6.8m
Lars Sandström
Chief Financial Officer2.25yrsno data0.0048% SEK2.6m
Lars Mattsson
Head of Investor Relationsno datano datano data
Lena Hagman
Executive Vice President of Quality & Regulatory Compliance4.17yrsno data0.0013% SEK717.4k
Abraham Ronai
General Counselno datano datano data
Jeanette Carlsson
Executive Vice President of Communications & Brand Management2.75yrsno datano data
Magnus Lundbäck
Executive Vice President of Human Resources & Sustainability3.17yrsno data0.00037% SEK198.1k
Dieter Engel
Chief Technology Officer of Surgical Workflows4.17yrsno datano data
Carsten Blecker
Chief Commercial Officer2.25yrsno data0.00037% SEK198.1k
Jens Viebke
President of Acute Care Therapiesno datano data0.00040% SEK214.1k

3.0yrs

Average Tenure

52yo

Average Age

Experienced Management: GETI B's management team is considered experienced (3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Mattias Perjos
CEO, President & Director3yrskr46.04m0.013% SEK6.8m
Johan Bygge
Independent Director12.92yrskr852.00k0.054% SEK28.9m
Carl Bennet
Vice Chairman of Board0.17yrkr684.00k20.03% SEK10.7b
Malin Persson
Independent Director6.17yrskr684.00k0.0019% SEK1.0m
Johan Stern
Director16.17yrskr684.00k0.014% SEK7.3m
Johan Malmquist
Chairman0.92yrkr1.31m0.033% SEK17.7m
Cecilia Wennborg
Independent Director9.92yrskr722.00k0.0016% SEK883.3k
Barbro Fridén
Independent Director3yrskr684.00k0.00011% SEK58.9k
Peter Jörmalm
Employee Representative Director2.17yrsno datano data
Rickard Karlsson
Employee Representative Director7.17yrsno datano data

4.6yrs

Average Tenure

59yo

Average Age

Experienced Board: GETI B's board of directors are considered experienced (4.6 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: GETI B insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Getinge AB's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Getinge AB
  • Ticker: GETI B
  • Exchange: OM
  • Founded: 1904
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: kr53.534b
  • Shares outstanding: 272.37m
  • Website: https://www.getinge.com

Number of Employees


Location

  • Getinge AB
  • Lindholmspiren 7
  • Gothenburg
  • Västra Götaland County
  • 417 56
  • Sweden

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
GNGB.FOTCPK (Pink Sheets LLC)YesClass B SharesUSUSDMay 1993
GETI BOM (OMX Nordic Exchange Stockholm)YesClass B SharesSESEKMay 1993
GTNDB (Deutsche Boerse AG)YesClass B SharesDEEURMay 1993
0GZVLSE (London Stock Exchange)YesClass B SharesGBSEKMay 1993
GETIBSBATS-CHIXE (BATS 'Chi-X Europe')YesClass B SharesGBSEKMay 1993
GNGB.YOTCPK (Pink Sheets LLC)UNSPONSORD ADRUSUSDOct 2008

Biography

Getinge AB provides products and solutions for operating rooms, intensive-care units, sterilization departments, and life science companies and institutions. The company operates through Acute Care Therapies, Surgical Workflows, and Life Science segments. It offers practice-oriented monitoring systems and disposables; anesthesia, beating heart surgery, and ceiling devices; washer-disinfectors, consumables, and IT-solutions; connected solutions; consumables products; drain products; endoscope reprocessing; endoscopic vessel harvesting systems; extracorporeal life support or extracorporeal membrane oxygenation products; inspection and packaging services; intra-aortic balloon counter pulsation therapies; critical care ventilators; modular room systems; operating lights; operating tables and accessories; operating room (OR) furniture; OR integration systems; patient flow management solutions; patient transport solutions; sealing equipment; sterile supply management and traceability solutions; sterilizers; surgical assist systems; surgical perfusion components; loading and distribution trolleys; trays and baskets; and after sales consulting services. The company also provides automated bedding handling equipment, closure processing systems, washers, and isolation and sterile transfer products; professional financial advisory services to hospitals and medical facilities; and education and training services. It offers its products through a network of proprietary sales companies, as well as through agents and distributors in Europe, the Middle East, Africa, the Americas, Asia, and Pacific. The company has a strategic partnership with Verb Surgical Inc. to develop digital surgery solutions. Getinge AB was founded in 1904 and is headquartered in Gothenburg, Sweden. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/03/30 20:59
End of Day Share Price2020/03/30 00:00
Earnings2019/12/31
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.